B. Longo

Determinants of SARS-CoV-2 Contagiousness in Household Contacts of Symptomatic Adult Index Cases

P. Vineis, L. Richiardi, G. di Perri, 2022, Frontiers in Microbiology.

Diagnostic SARS-CoV-2 Cycle Threshold Value Predicts Disease Severity, Survival, and Six-Month Sequelae in COVID-19 Symptomatic Patients

G. di Perri, A. Calcagno, Francesco Venuti, 2021, Viruses.

On the SARS-CoV-2 “Variolation Hypothesis”: No Association Between Viral Load of Index Cases and COVID-19 Severity of Secondary Cases

G. di Perri, A. Calcagno, Francesco Venuti, 2021, Frontiers in Microbiology.

Real-Life Experience of Continuously Infused Ceftolozane/Tazobactam in Patients with Bronchiectasis and Multidrug-Resistant Pseudomonas aeruginosa Infection in the Outpatient Setting

G. Stroffolini, A. Calcagno, A. de Nicolò, 2023, Antibiotics.

Sequential or Combination Treatments as Rescue Therapies in Immunocompromised Patients with Persistent SARS-CoV-2 Infection in the Omicron Era: A Case Series

T. Lupia, F. D. De Rosa, A. Calcagno, 2023, Antibiotics.

Transient plasma viral rebound after SARS-CoV-2 vaccination in an exceptional HIV-1 elite controller woman

A. Calcagno, T. Allice, S. Bonora, 2023, Virology Journal.

Risk factors for mortality in Acinetobacter baumannii bloodstream infections and development of a predictive mortality model.

F. D. De Rosa, S. Scabini, S. Corcione, 2024, Journal of global antimicrobial resistance.